Dr. Zhiyuan Gong is a professor at Department of Biological Sciences, National University of Singapore. He obtained his B.Sc in 1982 from Ocean University of China, Qingdao, China, and Ph.D in 1987 from McGill University, Montreal, Canada. After postdoctoral research careers at University of Toronto, he became a faculty member at the National University of Singapore in 1995.
In his postdoctoral research career, Dr. Gong has been involved in the well-publicized work for generating growth hormone transgenic salmon which has been marketed as AquAdvantage salmon and recently approved by FDA. In his independent research career, he developed several fluorescent transgenic zebrafish and these fish with trademark GloFishTM have become the first genetically modified pet commercially available in USA. In recent years, his research interests have been extended to using the zebrafish for environmental toxicology and modelling human diseases. Currently his group is focusing on the hormonal role in sex disparity of liver cancers in zebrafish. So far, he has published 193 research papers and 31 reviews/book chapters on these topics. He is currently an editor for Journal of Fish Biology and Plos One. He is a board member of Zebrafish Diseases Models Society and Asia-Pacific Marine Biotechnology Conference. He received the inaugural Outstanding Scientist Award in 2007 from Faculty of Science, National University of Singapore.
In his postdoctoral research career, Dr. Gong has been involved in the well-publicized work for generating growth hormone transgenic salmon which has been marketed as AquAdvantage salmon and recently approved by FDA. In his independent research career, he developed several fluorescent transgenic zebrafish and these fish with trademark GloFishTM have become the first genetically modified pet commercially available in USA. In recent years, his research interests have been extended to using the zebrafish for environmental toxicology and modelling human diseases. Currently his group is focusing on the hormonal role in sex disparity of liver cancers in zebrafish. So far, he has published 193 research papers and 31 reviews/book chapters on these topics. He is currently an editor for Journal of Fish Biology and Plos One. He is a board member of Zebrafish Diseases Models Society and Asia-Pacific Marine Biotechnology Conference. He received the inaugural Outstanding Scientist Award in 2007 from Faculty of Science, National University of Singapore.